Aspire Cristalle (system of digital mammography)

2019

Emergence of function of a biopsy with a digital tomosintez of a mammary gland

In the middle of July, 2019 the Fujifilm Medical Systems company officially submitted the updated digital mammographic Aspire Cristalle system with a new feature of a biopsy on the basis of a digital tomosintez.

The Fujifilm Aspire Cristalle system combines the most modern technology of capture of images and intellectual processing of pictures, optimizing a dose and contrast on the basis of the individual structure of a mammary gland. For the first time the shown on RSNA 2018, new option of a system serves as addition to a traditional method of a stereotaksichesky biopsy and uses tomosintez for calculation of three-dimensional coordinates of damages of a mammary gland. It will allow radiologists to execute precisely a biopsy of suspicious sections, to conduct patomorfologichesky examination and to develop the plan of diagnostics and treatment.

According to the developer, the new option allows to find even those defeats which were not shown in full-height digital mammographic pictures earlier. Use of models on the basis of a tomosintez for a biopsy instead of traditional 2D - images provides the clinical physician with more convenient means of navigation. Besides, the platform is rather simple in use as it is supplied with a double display system of pictures with high resolution, function of aiming at stereoimages and different options of image processing.

Fujifilm considers that the biopsy with a digital tomosintez will allow radiologists to estimate precisely location of suspicious areas and also to carry out the analysis of these sections with higher clinical reliability and efficiency. Now clinical physicians will have more opportunities for diagnosis, and the biopsy on the basis of a tomosintez optimizes workflow, reducing inspection duration.^[1]

Fujifilm submitted applications for improvement of quality of mammograms

In the middle of March, 2019 the Fujifilm Medical Systems company released three new software tools for image processing intended for the system of digital mammography Aspire Cristalle. The provided S-View, ISR and Tomosynthesis Spot applications should provide higher quality of mammograms at a smaller dose of radiation, having added the existing software package on optimization of a dose.

S-View allows radiologists to receive synthesized 2D - images according to a tomography: according to developers, S-View can be used together with images of KT-cuts both for screening, and for diagnosis of diseases of a mammary gland. According to the company, use of S-View instead of specialized 2D - mammographies allows the oncological centers to lower a dose approximately by 50%.

In the middle of March, 2019 the Fujifilm Medical Systems company released three new software tools for image processing intended for the system of digital mammography Aspire Cristalle

ISR is the application for a new method of the data recovery based on technologies of automatic recognition. ISR details the image and reduces noise, exceeding normal methods of filtering on these indicators. Thanks to improvement of traditional methods of iterative recovery, ISR recovers images with higher resolution, than initially data retrieveds that increasing detailing and reducing noise without prejudice to the speed of holding an initial procedure.

Tomosynthesis Spot was developed for creation of images during a tomosintez. This application allows to visualize a specific problem area precisely.

The Aspire Cristalle system with new applications will be submitted at the stand of Fujifilm at a conference of National consortium of the centers of a mammary gland (NCoBC) in Las Vegas and on a symposium of Society of visualization of mammary glands (SBI) in the State of Florida at the beginning of April, 2019.^[2]

Notes